Only a small number of palliative-care patients in Ontario will be affected by the province’s plan to stop paying for high-dose opioid medications under its public drug programs, a new study shows.
Only a small number of palliative-care patients in Ontario will be affected by the province’s plan to stop paying for high-dose opioid medications under its public drug programs, a new study shows.